Abstract
This letter to the editor comments on a recently published article about differences in the characteristics of pain and subsequent analgesia with the use of breakthrough medications in patients with cancer pain, pointing out three key questions for ideal management of breakthrough cancer pain.
| Original language | English |
|---|---|
| Pages (from-to) | e1133 |
| Number of pages | 1 |
| Journal | Oncologist |
| Volume | 25 |
| Issue number | 7 |
| DOIs | |
| Publication status | Published - Jul 2020 |
| Externally published | Yes |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- opioids
- breakthrough pain
- cancer pain
- breakthrough medications
Fingerprint
Dive into the research topics of 'Opioids for Breakthrough Cancer Pain'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver